Drug Clinical Trials List
Drug Clinical Trials List
| Study Title | Study Sponsor | Status | Study Drug | Trial Phase | Study Protocol Number | Site |
|---|---|---|---|---|---|---|
| V212-001 A Phase III Randomized, Placebo-Controlled, Clinical Trial to Study the Safety and Efficacy of V212 in Adult Patients With Solid Tumor or Hematologic Malignancy | MSD | Completed | V212 | 3 | V212-011 | KFSH |
| Treatment of Neuroendocrine Tumors (NETs) with combination of Everolimus and Radiolabeld Somatostatin Analogue" | King Faisal Specialist Hospital and Research Centre | Ongoing | Everolimus | 2 | ONC-CRC 12- 12 or (RAC # 2121 159) | KFSH & RC-R |
| "Tranexamic acid for the treatment of significant traumatic brain injury: an international randomised, double blind placebo controlled trial" | London School of Hygiene & Tropical Medicine (LSHTM) | Ongoing | (Cyklokapron) Tranexamic Acid | 3 | ISRCTN15088122 | KSMC |
| "Tranexamic acid for the treatment of gastrointestinal hemorrhage: an international randomized, double-blind, placebo-controlled trial" | Prince Mohammad Bin Abdulaziz Hospital | Ongoing | Tranexamic acid | 3 | ISRCTN11225767 | PMBAH |
| Tocilizumab Efficacy and Safety in RA Patients After Inadequate Response to DMARDs or Anti-TNF | Roche | Completed | Tocilizumab | 3 | ML22726 | KFSH |
| THydroxychloroquine versus Standard of Care for the Management of COVID-19 | King Abdulaziz University Hospital | Completed | Hydroxychloroquine sulphate | 3 | 249-20 | KAUH-J |
| Therapeutic Effects of Colchicine in the Treatment of Symptomatic and Acute Respiratory Distress Syndrome in COVID-19 Patients | KACST | Completed | Colchicine | 3 | 5200107 | DCH |
| The study of efficacy and saftey of Rituximab in treatment of resistant glomerulonephritis | The Saudi center for Organ Transplantation (SCOT) | Completed | Rituximab | 3 | MN-101-11 | KFMC |
| "The efficacy of Leukotriene Inhibitor in Adult Patients with mild and moderate SARSCOV- 2 symptoms (COVID19): (Randomized Clinical Trial)" | KAIMRC | Ongoing | Zafirlukast | 2 | RC20/206/R | King Abdulaziz Medical City NG (Riyadh) |
| The Efficacy of an anti-inflammatory/antioxidant oral nutrition Supplementation on the Progression of COVID-19 in SARS-CoV-2 positive cases: A Randomized Controlled Trial | General Directorate of Research and Studies, Ministry of Health | Ongoing | Dietary Supplement containing Vitamins A, C, E, selenium and Zinc | 3 | 20092202 | Prince Mohammad bin Abdulaziz hospital (Riyadh) |